For patients who cannot tolerate taxanes, alternative chemotherapeutic agents such as anthracyclines or platinum-based drugs may be considered. Additionally, targeted therapies and immunotherapies offer treatment options with different side effect profiles. The choice of alternative therapy depends on the specific cancer type, stage, and patient characteristics.
